AstraZeneca completes $1.26B Ardea purchase
11:17 EDT 20 Jun 2012 | PharmPro
AstraZeneca PLC said Wednesday that it completed its $1.26 billion acquisition of gout drug developer Ardea Biosciences Inc.AstraZeneca agreed to buy Ardea in April for $32 per share, a 54 percent premium to the stock's closing price the trading day..
Original Article: AstraZeneca completes $1.26B Ardea purchase
More From BioPortfolio on "AstraZeneca completes $1.26B Ardea purchase"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
